Quick Answer
ATOSSA THERAPEUTICS, INC. reported Net Income of -$34.77 million for fiscal year 2025.
ATOSSA THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$34.77M | -36.3% |
| 2024 | -$25.50M | +15.3% |
| 2023 | -$30.09M | -11.6% |
| 2022 | -$26.96M | -30.8% |
| 2021 | -$20.61M | -15.6% |
| 2020 | -$17.83M | -3.4% |
| 2019 | -$17.24M | -51.2% |
| 2018 | -$11.40M | -40.4% |
| 2017 | -$8.12M | -27.5% |
| 2016 | -$6.37M | +59.6% |
| 2015 | -$15.76M | -7.5% |
| 2014 | -$14.66M | -35.9% |
| 2013 | -$10.78M | -112.3% |
| 2012 | -$5.08M | -47.6% |
| 2011 | -$3.44M | -216.7% |
| 2010 | -$1.09M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.69M | -20.2% | -3.2% |
| June 30, 2025 | -$8.42M | -39.2% | -25.4% |
| March 31, 2025 | -$6.72M | -14.3% | +7.1% |
| September 30, 2024 | -$7.23M | -16.1% | -19.5% |
| June 30, 2024 | -$6.05M | +38.5% | -2.9% |
| March 31, 2024 | -$5.88M | +6.4% | +5.6% |
| September 30, 2023 | -$6.23M | +22.2% | +36.6% |
| June 30, 2023 | -$9.83M | -47.3% | -56.5% |
- ATOSSA THERAPEUTICS, INC. showed a decrease of -36.3% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, ATOSSA THERAPEUTICS, INC.’s net income has declined by 3098.9% (from -$1.09 million to -$34.77 million).
- The most recent figure is from ATOSSA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: